A large review found that using GLP-1 drugs increases the chance of gallbladder or bile duct disease, especially at higher doses, for longer periods, or when used for weight loss
For instance, changes in the levels of calcium, oxalate, and citrate in urine can significantly impact the risk of stone development
Pemvidutide vs Survodutide: GLP-1/Glucagon Dual Agonist Comparison for Obesity and MASH Evidence-based comparison of pemvidutide and survodutide, two GLP-1/glucagon dual receptor agonists being developed for obesity and MASH based on Phase 2 clinical trial data
This content is educational and is not considered medical advice
How common is leaky gut
Pre-Ramadan Checklist: How to Use Weight Loss Injections During Ramadan Preparation is key to staying safe, healthy, and confident while fasting on weight loss injections